Detection and quantification of SARS-CoV-2 are important in clinical research to understand the impact of SARS-CoV-2 and the significance of prolonged viral shedding.
This whitepaper from Waters Corporation demonstrates the capabilities of the SARS-Cov-2 LC-MS Kit (RUO) to directly detect and quantify low levels of SARS-CoV-2 signature nucleocapsid peptides without the need to amplify the target analytes — as required for PCR — and with the ability to measure multiple analytes at a time.
Offered Free by: Waters Corporations
See All Resources from: Waters Corporations
This download should complete shortly. If the resource doesn't automatically download, please, click here.